Drug Profile
Research programme: pain and inflammation therapeutics - Xel
Alternative Names: XEL 002BG; XEL 002BI; XEL 002BP; XEL 002LG; XEL 004FPLatest Information Update: 07 Jan 2016
Price :
$50
*
At a glance
- Originator Xel Pharmaceuticals
- Class Alkaloids
- Mechanism of Action Serotonin modulators; Sodium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammation; Pain
Most Recent Events
- 07 Jan 2016 Discontinued - Preclinical for Inflammation in USA (Parenteral)
- 07 Jan 2016 Discontinued - Preclinical for Inflammation in USA (Topical)
- 07 Jan 2016 Discontinued - Preclinical for Inflammation in USA (Transdermal)